Inventor · disambiguated record
Joseph S. Zakrzewski
Also filed as: ZAKRZEWSKI JOSEPH S
17 granted patents·11 pending applications·212 citations·filing 2013–2020
94Inventor score
Files withAMARIN PHARMACEUTICALS IE LTD28
Top patents by PatentIndex Score
28 records- 0199US10973797B2Methods of reducing apolipoprotein c-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Apr 13, 2021·9 cites·20 claims
- 0299US10166209B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2015·Granted Jan 1, 2019·64 cites·7 claims
- 0398US11185525B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Nov 30, 2021·9 cites·24 claims
- 0498US10265290B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Apr 23, 2019·64 cites·8 claims
- 0597US10610508B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2018·Granted Apr 7, 2020·11 cites·20 claims
- 0697US9452151B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Sep 27, 2016·17 cites·9 claims
- 0794US10851374B2Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2018·Granted Dec 1, 2020·5 cites·22 claims
- 0894US9855240B2Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2016·Granted Jan 2, 2018·9 cites·20 claims
- 0993US9624492B2Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Apr 18, 2017·9 cites·10 claims
- 1089US10206898B2Compositions and methods for treating or preventing obesity in a subject in need thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2016·Granted Feb 19, 2019·3 cites·15 claims
- 1189US9283201B2Compositions and methods for treating or preventing obesity in a subject in need thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Mar 15, 2016·5 cites·14 claims
- 1287US10167467B2Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted Jan 1, 2019·2 cites·8 claims
- 1385US10675263B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2018·Granted Jun 9, 2020·2 cites·20 claims
- 1482US9814733B2Compositions comprising EPA and obeticholic acid and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Nov 14, 2017·2 cites·17 claims
- 1577US9662307B2Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted May 30, 2017·1 cites·20 claims
- 1675US2021145787A1Methods of reducing apolipoprotein c-iiiAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 1771US2021108202A1Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 1869US11141399B2Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosisAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Oct 12, 2021·0 cites·11 claims
- 1968US2015065572A1Methods of treating or preventing prostate cancerAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 2067US10888539B2Methods of treating or preventing prostate cancerAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted Jan 12, 2021·0 cites·18 claims
- 2166US2021145786A1Methods of treating or preventing prostate cancerAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 2255US2015045431A1Methods of treating a cardiovascular disorder in a subject on apo-c3 modulating therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 2355US2015073050A1Co-administration of omeprazole and eicosapentaenoic acid or a derivative thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 2455US2015051282A1Methods of treating a cardiovascular disorder and/or joint pain in a subject on glucosamine therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 2553US2014271907A1Compositions comprising eicosapentaenoic acid and krill oil and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 2653US2014221358A1Compositions comprising eicosapentaenoic acid and diazoxide and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 2753US2014275252A1Methods of treating traumatic brain injuryAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 2853US2014221452A1Compositions comprising eicosapentaenoic acid and 5-htp and methods of use thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →